Tumor necrosis factor-alpha inhibitor use for treatment of refractory cardiac sarcoidosis in a patient with left ventricular assist device: Adalimumab use in refractory sarcoidosis in a patient with left ventricular assist device.

MedStar author(s):
Citation: Journal of Heart & Lung Transplantation. 39(12):1504-1505, 2020 12.PMID: 32830024Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): LetterSubject headings: *Adalimumab/tu [Therapeutic Use] | *Cardiomyopathies/th [Therapy] | *Heart Failure/th [Therapy] | *Heart-Assist Devices | *Sarcoidosis/th [Therapy] | *Tumor Necrosis Factor-alpha/ai [Antagonists & Inhibitors] | Adult | Anti-Inflammatory Agents/tu [Therapeutic Use] | Cardiomyopathies/co [Complications] | Cardiomyopathies/di [Diagnosis] | Female | Heart Failure/di [Diagnosis] | Heart Failure/et [Etiology] | Humans | Positron-Emission Tomography | Sarcoidosis/co [Complications] | Sarcoidosis/di [Diagnosis] | Treatment OutcomeYear: 2020ISSN:
  • 1053-2498
Name of journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart TransplantationAll authors: Cupps TR, Krishnan M, Sheikh FHOriginally published: Journal of Heart & Lung Transplantation. 39(12):1504-1505, 2020 12.Fiscal year: FY2021Digital Object Identifier: Date added to catalog: 2020-09-02
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 32830024 Available 32830024

English

Powered by Koha